Routine proxy filing with no material financial impact. Monitor the meeting outcome for any unexpected vote results, but no immediate trading catalyst.
Price Chart
Executive Summary
Atea Pharmaceuticals filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting, scheduled for June 18, 2026. The board recommends voting 'For' the election of three Class III director nominees, ratification of KPMG as auditor, and advisory approval of executive compensation. No contest or activist involvement is present.
Key Financial Metrics
Key Facts
- Annual meeting to be held virtually on June 18, 2026 at 9:00 AM ET
- Proposal 1: Election of Class III directors - Jerome Adams, Howard Berman, Barbara Duncan
- Proposal 2: Ratification of KPMG LLP as independent auditor for FY 2026
- Proposal 3: Advisory (non-binding) vote on named executive officer compensation
- Board recommends 'For' on all proposals
- Voting deadline is June 17, 2026 at 11:59 PM ET
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-182340 |
| Document: 0001193125-26-182340-index-headers.html | 0001193125-26-182340 |
| Document: 0001193125-26-182340-index.html | 0001193125-26-182340 |
| Document: 0001193125-26-182340.txt | 0001193125-26-182340 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | SC 13G | $5.01 | awaiting T+60 | — | $4.17 (−16.77%) |
Jul 14, 2026 15w ago | Press Release | $4.70 $5.01 | ▲ +6.60% | ▲ +3.22% | $4.17 (−11.28%) |
May 12, 2026 24w ago | Press Release | $4.57 $5.25 | ▼ −14.88% | ▼ −10.44% | $4.17 (+8.75%) |
Apr 27, 2026 26w ago | DEFA14A | $5.58 $4.75 | ▼ −14.87% | ▼ −18.86% | $4.17 (−25.27%) |
Mar 5, 2026 33w ago | 8-K | $5.89 $4.38 | ▼ −25.64% | ▼ −38.42% | $4.17 (−29.20%) |
Mar 5, 2026 33w ago | Press Release | $5.89 $4.38 | ▼ −25.64% | ▼ −38.42% | $4.17 (−29.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers